Cargando…
Glycosyltransferase B4GALNT2 as a Predictor of Good Prognosis in Colon Cancer: Lessons from Databases
Background: glycosyltransferase B4GALNT2 and its cognate carbohydrate antigen Sd(a) are highly expressed in normal colon but strongly downregulated in colorectal carcinoma (CRC). We previously showed that CRC patients expressing higher B4GALNT2 mRNA levels displayed longer survival. Forced B4GALNT2...
Autores principales: | Pucci, Michela, Malagolini, Nadia, Dall’Olio, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122605/ https://www.ncbi.nlm.nih.gov/pubmed/33919332 http://dx.doi.org/10.3390/ijms22094331 |
Ejemplares similares
-
High Expression of the Sd(a) Synthase B4GALNT2 Associates with Good Prognosis and Attenuates Stemness in Colon Cancer
por: Pucci, Michela, et al.
Publicado: (2020) -
The Sd(a) Synthase B4GALNT2 Reduces Malignancy and Stemness in Colon Cancer Cell Lines Independently of Sialyl Lewis X Inhibition
por: Pucci, Michela, et al.
Publicado: (2020) -
Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models
por: Pucci, Michela, et al.
Publicado: (2022) -
The Cancer-Associated Antigens Sialyl Lewis(a/x) and Sd(a): Two Opposite Faces of Terminal Glycosylation
por: Dall’Olio, Fabio, et al.
Publicado: (2021) -
Glycobiology of the Epithelial to Mesenchymal Transition
por: Pucci, Michela, et al.
Publicado: (2021)